Medical Minds

Medical Minds

We dive deep into the minds of our amazing researchers to find out how they tick and how they are working to make our lives better.

00:00
00:00

Avsnittssammanfattning

Autoimmune diseases affect one in eight people, yet many are still treated by suppressing the entire immune system. But what if all of them shared a common root cause – a small number of rogue immune cells that could be identified and removed? In this episode, Garvan's Professor Chris Goodnow explains how he's tracking down these 'rogue clones', and how targeting them could pave the way for more effective treatments for autoimmune diseases. Support Garvan research: https://www.garvan.org.au/support-us/give-now See omnystudio.com/listener for privacy information.

Avsnitt

38-

Finding the needle in the haystack

Autoimmune diseases affect one in eight people, yet many are still treated by suppressing the entire immune system. But what if all of them shared a common root cause – a small number of rogue immune cells that could be identified and removed? In this episode, Garvan's Professor Chris Goodnow explains how he's tracking down these 'rogue clones', and how targeting them could pave the way for more effective treatments for autoimmune diseases. Support Garvan research: https://www.garvan.org.au/support-us/give-now See omnystudio.com/listener for privacy information.

15 Okt 2026
37-

Storming the tumour fortress

Pancreatic cancer can surround itself with dense scar tissue, creating a kind of fortress that makes tumours incredibly difficult to treat. So, how do we find a way through? In this episode, Garvan researcher Dr Brooke Pereira explains the role of this complex tumour environment, and reveals how better understanding it could be the key to uncovering new treatment options. Support Garvan research: https://www.garvan.org.au/support-us/give-now See omnystudio.com/listener for privacy information.

22 Sep 2026
36-

Hunting hidden cells

Our immune system is like a well-trained security network, constantly scanning the body for threats. So, how is it that some harmful cells manage to slip by unnoticed? In this episode, we speak to computational biologist, Dr Clare Puttick, about how cancer cells can evade detection by disrupting the molecular “flags” that would normally mark them for attack. Her research is uncovering new ways to expose these hidden cells and could offer fresh insights into diseases where the immune system doesn’t behave as expected, including endometriosis. Support Garvan research: https://www.garvan.org.au/support-us/give-now See omnystudio.com/listener for privacy information.

19 Jun 2026
35-

The missing piece of the puzzle

What if the missing piece in diagnosing, and even treating, a rare disease was hiding in plain sight? For one such condition, mevalonate kinase deficiency, which affects at least one in a million people globally, that piece may now have been uncovered. In this episode, Garvan's Professor Mike Rogers shares insights from more than a decade of research into this condition, and explains how his findings are helping reveal a bigger picture. Support Garvan research: https://www.garvan.org.au/support-us/give-now See omnystudio.com/listener for privacy information.

17 Apr 2026
34-

Calling killer cells to action

Immunotherapy has revolutionised the treatment of many blood cancers, harnessing the immune system so our bodies can fight back. But for solid tumours, like pancreatic cancer with a survival rate of just 13%, that breakthrough has remained frustratingly out of reach. In this episode, we explore why the immune system struggles to attack these tumours and how the physical environment inside cancers can shape the way immune cells behave. We hear from Garvan's Associate Professor Maté Biro, whose research maps how cells move inside of tumours, with the goal of uncovering new strategies to improve cancer treatment. Support Garvan research: https://www.garvan.org.au/support-us/give-now See omnystudio.com/listener for privacy information.

16 Mar 2026